Medtronic plc
MDT- Exchange
- NYSE
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001613103
In the last 90 days, Medtronic plc insiders filed 0 open-market purchases and 3 sales; 2,156 institutions reported holding it in 13F filings for Q2 2026, worth $86.8B in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 13, 2026
- $131.6B
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $5.89M in total
- 3
- 13F holdersQ2 2026, −78 vs. previous quarter
- 2,156
- 13F valueReported value at the end of Q2 2026
- $86.8B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2026
- $36.4B
- +8.4% year over year
- Net income, FY2026
- $4.80B
- +3.0% year over year
- Free cash flow, FY2026
- $5.43B
- +4.6% year over year
- Revenue, Q1 FY2027
- $9.76B
- +13.7% year over year
Revenue flow, FY2026
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 23.0M
- Shares sold short
- Change
- −116.1M
- −83.5% vs. previous
- Days to cover
- 1.86
- At average daily volume
Superinvestors holding MDT, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding MDT at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Medtronic plc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 16, 2026 (view filing)6:02 PM ET | Oct 15 | 1 day | Marinaro MichaelEVP, Pres MedSurg and Americas | SSale | −10.4K | $96.00 | −$1.00M | −9.0%105.9K after | 10b5-1 |
| Oct 16, 2026 (view filing)6:00 PM ET | Oct 15 | 1 day | Martha GeoffreyChairman and CEO | SSale | −50.0K | $95.00 | −$4.75M | −15.3%277.9K after | 10b5-1 |
| Sep 17, 2026 (view filing)4:17 PM ET | Sep 16 | 1 day | Kiil Harry SkipEVP & President Cardiovascular | SSale | −1.48K | $93.65 | −$138.9K | −3.4%42.2K after | |
| Jul 9, 2026 (view filing)4:26 PM ET | Jul 8 | 1 day | Walter Matthew R.SVP, Chief HR Officer | SSale | −3.10K | $83.15 | −$257.9K | −8.0%35.7K after | 10b5-1 |
| Jun 9, 2026 (view filing) | Jun 8 | 1 day | Kiil Harry SkipEVP & President Cardiovascular | SSale | −4.19K | $80.44 | −$337.0K | −10.1%37.2K after | 2 lots |
| Feb 26, 2026 (view filing) | Feb 19 | 7 daysLate | Kiil Harry SkipEVP & President Cardiovascular | SSale | −52.5K | $97.71 | −$5.13M | −61.6%32.8K after | 5 lots |
| Nov 21, 2025 (view filing) | Nov 19 | 2 days | Smith Gregory LEVP Global Ops & Supply Chain | SSale | −30.0K | $101.95 | −$3.06M | −39.5%46.0K after | 7 lots |
| Sep 5, 2025 (view filing) | Sep 3 | 2 days | Kiil Harry SkipEVP & President Cardiovascular | SSale | −8.61K | $91.58 | −$788.0K | −19.5%35.6K after | 2 lots |
| Aug 25, 2025 (view filing) | Aug 22-25 | 3 days | Jellison William RDirector | PPurchase | +5.00K | $92.55 | +$462.8K | New position5.00K after | 2 lots |
| Jan 27, 2025 (view filing) | Jan 24 | 3 days | Wall Brett A.EVP & Pres Neuroscience | SSale | −12.4K | $90.00 | −$1.12M | −23.3%41.0K after | 10b5-1 |
Top 10 13F holders, Q2 2026
See all 2,156 holdersThe largest institutional positions in Medtronic plc at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 114,020,787 | $8.92B | 0.13% | +838,220+0.7% | Added |
| Vanguard Capital Management LLC | 83,816,735 | $6.56B | 0.14% | +482,902+0.6% | Added |
| State Street Corp | 63,399,315 | $5.01B | 0.15% | +1,658,301+2.7% | Added |
| Vanguard Portfolio Management LLC | 34,059,967 | $2.66B | 0.12% | +609,409+1.8% | Added |
| Massachusetts Financial Services Co | 19,872,600 | $2.61B | 0.83% | −1,564,999−7.3% | Reduced |
| Geode Capital Management, LLC | 30,192,015 | $2.35B | 0.13% | +1,455,674+5.1% | Added |
| JPMorgan Chase & Co | 27,784,471 | $2.25B | 0.13% | −23,189,070−45.5% | Reduced |
| Bank of America Corp | 21,322,401 | $1.67B | 0.11% | −4,692,602−18.0% | Reduced |
| Morgan Stanley | 19,444,871 | $1.52B | 0.08% | −1,272,158−6.1% | Reduced |
| Deutsche Bank AG | 18,449,877 | $1.44B | 0.42% | −552,537−2.9% | Reduced |
Holders of 5% or more of MDT
See all 3 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Medtronic plc.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 13G | 7.51%96.4M shares | New | Apr 28, 20261 filing | Apr 28, 2026 | SEC |
| BlackRock, Inc. | 13G/A | 6.90%88.7M shares | – | Apr 23, 20251 filing | Apr 23, 2025 | SEC |
| State Street Corp | 13G | 5.20%66.1M shares | New | Nov 10, 20261 filing | Nov 10, 2026 | SEC |
Politician trades
All politician trades in MDT38 members of Congress reported 92 trades in Medtronic plc since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Sep 1, 2026 |  Kevin Hern House · OK | Sell | $15K-$50K |
| Aug 14, 2026 |  Richard McCormick House · GA | Sell | $1K-$15K |
| Aug 5, 2026 |  Tommy Tuberville Senate · AL | Sell (full) | $15K-$50K |
| Aug 5, 2026 |  Julie Johnson House · TX | Sell (partial) | $1K-$15K |
| Jul 21, 2026 |  Alan Armstrong Senate · OK | Buy | $1K-$15K |
House · OK · Sep 1, 2026
Sell$15K-$50K
House · GA · Aug 14, 2026
Sell$1K-$15K
Senate · AL · Aug 5, 2026
Sell (full)$15K-$50K
House · TX · Aug 5, 2026
Sell (partial)$1K-$15K
Senate · OK · Jul 21, 2026
Buy$1K-$15K